Smoothing Trio
NDC Package 10028-024-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Smoothing Trio is a . Marketed by Ultraceuticals Pty Limited, this product is identified by NDC 10028-024 and is authorized under FDA application part352.

Identification & Billing

NDC Package Code
10028-024-01
Package Description
1 KIT in 1 KIT * 30 mL in 1 BOTTLE * 100 mL in 1 TUBE (10028-025-01) * 200 mL in 1 TUBE
Product Code
10028-024
11-Digit Billing Format
10028002401

Clinical Specifications

Proprietary Name
Smoothing Trio
Dosage Form
-

Regulatory & Marketing

Labeler Name
Ultraceuticals Pty Limited
FDA Application #
part352
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
08-13-2020
End Marketing Date
06-30-2021
Listing Expiration
06-30-2021
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 10028-024-01 identifies a specific commercial package of 1 kit in 1 kit * 30 ml in 1 bottle * 100 ml in 1 tube (10028-025-01) * 200 ml in 1 tube of Smoothing Trio, labeled by Ultraceuticals Pty Limited. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ultraceuticals Pty Limited on August 13, 2020. The current certification is valid through June 30, 2021.

How is this Ultraceuticals Pty Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 10028002401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
10028-024-01
11-Digit CMS (5-4-2)
10028-0024-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.